Filing Flows › Comparisons › CERS vs TMCI
Cerus vs Treace Medical Concepts: CERS and TMCI compared
Cerus is the larger company: $57.7M of revenue in its latest quarter (Q3 2026) against $48.3M for Treace Medical Concepts (Q3 2026). Cerus is growing faster (+10% against -4% a year earlier). Cerus is more profitable, with an operating margin of 0.7% against -23.9%.
Where the money goes: CERS and TMCI
Cerus (CERS) · Q3 2026
Cerus, Q3 2026: revenue $57.7M (+10% year over year), operating margin 0.7%, net loss $580K, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.
Treace Medical Concepts (TMCI) · Q3 2026
Treace Medical Concepts, Q3 2026: revenue $48.3M (-4% year over year), operating margin -23.9%, net loss $12.6M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
| Cerus (CERS) | Treace Medical Concepts (TMCI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $57.7M | $48.3M |
| Revenue growth, Y/Y | +10% | -4% |
| Operating margin | 0.7% | -23.9% |
| Net earnings | −$580K | −$12.6M |
| Net margin | -1.0% | -26.0% |
| Operating cash flow | $3.0M | −$3.3M |
| Free cash flow | $2.4M | — |
Questions
Which is bigger, Cerus or Treace Medical Concepts?
Cerus is the larger company: $57.7M of revenue in its latest quarter (Q3 2026) against $48.3M for Treace Medical Concepts (Q3 2026).
Is Cerus or Treace Medical Concepts growing faster?
Cerus is growing faster (+10% against -4% a year earlier).
Which is more profitable, Cerus or Treace Medical Concepts?
Cerus is more profitable, with an operating margin of 0.7% against -23.9%.
More: Cerus earnings · how Cerus makes money · Treace Medical Concepts earnings · how Treace Medical Concepts makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.